U.S. Urinary Flow Meters Market Size, Share & COVID-19 Impact Analysis, By Type (PC Based and Non-PC Based), By End-user (Hospitals, Specialty Clinics, and Others), and Country Forecast, 2023-2030

The U.S. urinary flow meters market size was worth USD 6.87 million in 2022 and is projected to grow at a CAGR of 7.9% during the forecast period. 

Urinary flow meters are medical devices used to measure the rate of urine flow during urination. It plays a crucial role in diagnosing and monitoring conditions such as urinary tract obstruction, prostate enlargement, and evaluating overall bladder function in urological assessments.

The U.S. has observed a significant rise in the prevalence of urinary tract-related disease, which has led to an increasing number of adults, especially the geriatric population, seeking diagnosis and treatment. For instance, according to a research article published by the American Society of Clinical Oncology (ASCO), in the U.S., it was estimated that 288,300 men will be diagnosed with prostate cancer in 2023. Furthermore, increasing awareness about early diagnosis and the growing focus of market players on launching technologically advanced products in the country are expected to boost market growth.

Technological advancements such as wireless, advanced sensor technologies, and user-friendly interfaces for streamlined data analysis have led to a rising preference among healthcare providers. This has also led to more effective diagnosis and treatment of urological conditions, which is expected to result in the growth in the demand for uroflowmeters during the forecast period.

The outbreak of COVID-19 declined the adoption of uroflowmeters by urologists in the country. This was mainly due to the decrease in the patients visits in the healthcare facilities, to evaluate urological disorders.

LATEST TRENDS

Transition toward PC-based Uroflowmeters

In recent years, the market has witnessed a growing shift from non-PC based uroflowmeters to PC-based uroflowmeters due to the various benefits associated with these devices. These devices seamlessly integrate into clinical systems, such as electronic medical records (EMRs) in order to streamline the process of tracking patient data. This integration empowers healthcare industry professionals to make informed decisions efficiently

Moreover, companies are placing a strong emphasis on developing novel and innovative PC-based uroflowmeters to broaden their portfolio and capture a larger customer demographic. These novel and advanced products is expected to enhanced diagnostic capabilities to urologists in order to examine various urological disorders.

DRIVING FACTORS

Growing Geriatric Population to Boost the Demand for Uroflowmeters, Driving Market Growth

The growing burden of the geriatric population has stimulated the adoption of uroflowmeters in the U.S. market. The geriatric population increases the risk of urology-related problems such as benign prostate hyperplasia (BPH), urine leakage, and retention, which is expected to boost the demand for devices to diagnose these disorders at an early stage, thereby propelling the U.S. urinary flow meters market growth.

• For instance, a study published by NCBI in August 2022 cited BPH prevalence to be as high as 70.0% in the population aged between 60 and 69 years and more than 80% in those over 70 years in the U.S.

RESTRAINING FACTORS

High Cost of Uroflowmeters Might Hinder Market Growth

Despite the increased adoption of urinary flow meters in the country, the high cost associated with these devices may hamper their demand in the market. The prices of urinary flow meters vary based on their features and type. The novel and advanced devices cost thousand dollars, which is anticipated to hamper the its adoption in healthcare facility in the country.

SEGMENTATION

By Type Analysis

By type, the U.S. market is segmented into non-PC based and PC based

The PC based segment captured the largest U.S. urinary flow meters market share in 2022 due to the benefits associated with the meters, such as comprehensive patient monitoring, precise diagnostics, and efficient treatment adjustments for improved urological care. Furthermore, the increasing number of patients suffering from urinary tract infections (UTI) in the country is expected to drive the adoption of the devices, thereby propelling segment growth during the forecast period.

• For instance, according to an article published by the National Center for Biotechnology Information (NCBI) in May 2019, approximately 50.0%-60.0% of women in the U.S. have at least one UTI in their lives.

The non-PC-based segment is expected to grow at notable CAGR owing to the advantages offered by standard urine flow meters, such as easy use and handling and accurate analysis of urine flow. Moreover, the investments done by major key players for the development of such standalone urine flow meters for the analysis of urological disorders are expected to drive the segment during the forecast period.

By End-user Analysis

In terms of end-user, the U.S. urinary flow meters market is segmented into specialty clinics, hospitals, and others.

The hospitals accounted for the largest share and is expected to grow at a substantial CAGR during the forecast period owing to the rising patient pool of lower urinary tract-related diseases and the increasing number of patient visits suffering from kidney stones and bladder cancer to the hospitals, thereby boosting the segmental growth in the long-run.

• According to a 2020 annual survey conducted by the American Hospital Association (AHA), there were 6,093 hospitals in the U.S., and the total number of hospital admissions in the region was 33.3 million in 2020.

The specialty clinics segment is anticipated to grow at the highest CAGR during the forecast period. The growth is attributed to the rising preference for patients to visit specialty clinics and the increasing number of patients suffering from urology-related disorders across the country.

KEY INDUSTRY PLAYERS

The U.S. market depicts the presence of established and emerging companies operating in the market. Leading players, such as Medica S.p.A, and Laborie have a significant share of the market. These companies are emphasizing on new strategies, such as mergers, acquisitions, new subsidiaries, and introduction of devices to penetrate untapped market.

Some other companies with a considerable presence in the U.S. market for urinary flow meters include MINZE HEALTH, Prometheus, and other players. These companies are emphasizing the introduction and development of innovative products, which is anticipated to propel their revenue of the U.S. market.

LIST OF KEY COMPANIES PROFILED:

• MINZE HEALTH (Belgium)


• Prometheus (U.S.)


• Laborie (U.S.)


• Apex MediTech (India)


• Medica S.p.A (Italy)

KEY INDUSTRY DEVELOPMENTS:

• November 2023: Laborie announced a strategic equity investment in Bright Uro, a medical technology company from California, developing a wireless, catheter-free, urodynamic monitoring system.


• April 2023: MINZE HEALTH participated in the American Urology Association Meeting in Chicago. The company showcased its cloud-based uroflowmeters that can be used at hospitals and private practices.

REPORT COVERAGE

The market research report provides a detailed market analysis. The market report offers information related to key industry developments such as mergers and acquisitions, SWOT analysis of key companies, and market dynamics, including drivers, restraints, and growth opportunities. In addition, it includes an overview of the technological advancements in the market and the epidemiology of various urology disorders in the country. In addition, the impact of COVID-19 is covered in the report.

Report Scope & Segmentation